Potential Elements Of The WHO Global R&D Treaty: Tailoring Solutions For Disparate Contexts 29/01/2013 by Intellectual Property Watch 1 Comment Prof. Ryan Abbott analyzes the key components of the WHO proposal for a Global R&D Treaty and their potential impact on public health. The article proposes strategies to convert parties currently opposing the treaty, and argues that a stratified limited market-exclusivity regime has the capacity for a meaningful impact.
WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines 28/01/2013 by William New, Intellectual Property Watch 5 Comments The World Health Organization Executive Board today approved a modified resolution on neglected tropical diseases – after removing a reference to a working group on R&D for neglected diseases as “irrelevant”. The Board also discussed and took note of a report on poor quality medical products in the supply chain, and agreed to set another meeting on the issue before the May World Health Assembly, as well as set up a separate group on behaviours that lead to this problem.
Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor 28/01/2013 by William New, Intellectual Property Watch 5 Comments World Health Organization members on Friday held a tense discussion over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development for neglected diseases predominantly afflicting poor populations. The discussion may continue today, with the linkage of an agenda item on neglected tropical diseases and the report of an expert working group offering numerous ideas for addressing the problem.
Governments Put WHO’s Independence At Heart Of Reform Debate 25/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments Any employee who has been through a company reform knows that it can be an anxious and stressful period. The experience is no different for the 194 members of the World Health Organization representing their respective countries and the public health interests of their constituents. As the WHO Executive Board digs deep into the fundamental principles of organisational change, preserving the holy member-driven nature of the global public health authority has emerged as the most pressing priority.
IP Professionals Discuss Tech Transfer Potential In Humanitarian Business At WIPO 23/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment A global business association held a meeting at the World Intellectual Property Organization this week on IP market developments, including increasing opportunities in technology transfer for commercial purposes. The intimate gathering featured a line-up of high-level speakers, including WIPO Director General Francis Gurry.
UNITAID Seeks Bids For ‘Freedom To Operate’ IPR Analyses For HIV Products 22/01/2013 by Intellectual Property Watch Leave a Comment UNITAID, the drug purchasing facility affiliated with the World Health Organization, sees “great promise” in emerging diagnostic products for HIV treatment monitoring and diagnosis in remote regions. Now it is looking for someone to verify the freedom to operate of these tools, ensuring they are not intellectual property-encumbered.
Packed WHO Executive Board Agenda Highlights Need To Streamline Priorities 21/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments World Health Organization Director General Margaret Chan today opened the 132nd meeting of the Executive Board, the UN agency’s highest authority, emphasising the importance of cost-effectiveness and results-driven operations at a time of global economic austerity and precarious funding.
EPO Sees Record Patent Filings, Grants 18/01/2013 by Intellectual Property Watch 1 Comment The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.
Syngenta Opens Doors To Its Patented Technologies, For Easier But Not Free Access 18/01/2013 by Catherine Saez, Intellectual Property Watch 3 Comments A new innovation platform launched yesterday by Syngenta, the international agri-business company, means to broaden availability to some patented traits and technologies for vegetables, but also aims at opening new ways to use the intellectual property system.
Free Drugs Are “Crucial Part” Of Neglected Tropical Disease Fight 16/01/2013 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments The World Health Organization reports that unprecedented progress has been made in addressing 17 parasitic diseases affecting the world’s poorest populations. The public health authority attributes the gains, in large part, to the contributions of global partners, including drug contributions made by research-based pharmaceutical giants.